SCHEMBL6479708

SCHEMBL6479708

COCCOCOc1c(C(=O)c2cccc(Cc3ccccc3)c2)ccc2c(C)ccnc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 2/20 0.34
CNR1 P21554 1/20 0.34
GPR52 Q9Y2T5 2/20 0.33
KLKB1 P03952 1/20 0.33
KLK1 P06870 1/20 0.33
MCHR1 Q99705 1/20 0.33
SRC P12931 3/20 0.33
TGFBR1 P36897 3/20 0.33
RARG P13631 1/20 0.33
F2 P00734 1/20 0.33
ELANE P08246 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492605 0.90 CNR1 (0.36) ROCK1CNR1MCHR1F2ELANE
SCHEMBL6487683 0.85 ALDH1A1 (0.42) MEN1ALDH1A1HPGDKMT2ARAB9A
SCHEMBL6478551 0.80 CCR1 (0.39) ROCK1GPR52MEN1ALDH1A1HPGD
SCHEMBL6479592 0.78 KDM4E (0.39) RARGF2ELANEALDH1A1
SCHEMBL6480271 0.72 EGLN1 (0.43) ALDH1A1HPGDMPO
SCHEMBL6480612 0.68 HDAC1 (0.36) ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL6479505 0.66 CCR1 (0.41) MEN1ALDH1A1CYP2C9HPGDCYP2C19
SCHEMBL8003379 0.63 GAA (0.44) RARGALDH1A1GAACYP2C9NPC1
SCHEMBL6492314 0.63 EGLN1 (0.59) ALDH1A1
SCHEMBL4256922 0.61 HDAC3 (0.46) MEN1ALDH1A1GAAHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors ZHUANG LINGHANG (US) 2005-01-13 US disclosed
EP-1333831-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2003-08-13 EP disclosed
WO-2002036734-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors POLI, CYP51A1, DUT ROCK1 1905/4885CNR1 4200/4885GPR52 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.